ASCA plus pANCA vs either alone for CD vs UC

What is known

• For UC, the pANCA-positive/ASCA-negative combination gave sensitivity 50% and specificity 90%, described as more accurate than pANCA alone (sensitivity 50%, specificity 82%). ¹
• For CD, the ASCA-positive/pANCA-negative combination lowered sensitivity to 32% (from 40% for ASCA alone) with specificity unchanged at 100%. ¹
• A review reported combined markers yielded higher specificity than sensitivity, making them more useful for differentiating IBD subtypes than for population screening. ²
• In a Greek cohort, adding negative ASCA to positive pANCA did not significantly change UC performance, but pANCA-negative/ASCA-positive raised PPV for CD to 77%. ³

What is unknown / caveats

• One cohort found the pANCA+/ASCA- combination more accurate than pANCA alone for UC ¹, while the combination did not improve CD diagnosis in the same study ¹
• A Greek study found combining markers did not significantly change UC test performance but raised PPV for CD ³
• Small samples (e.g., only 16 UC patients in the main cohort) and single-center/referral populations may inflate predictive values ¹
• Consistently low sensitivity means these markers cannot replace current diagnostic tools ¹
• Whether combined testing improves accuracy depends on which disease is being identified and the metric prioritized. Gains are in specificity, not sensitivity.

References

1. Anand V, Russell AS, Tsuyuki R, Fedorak R. Perinuclear antineutrophil cytoplasmic autoantibodies and anti-Saccharomyces cerevisiae antibodies as serological markers are not specific in the identification of Crohn's disease and ulcerative colitis. Can J Gastroenterol. 2008;22(1):33-6. PMID: 18209778.

2. Turkay C, Kasapoglu B. Noninvasive methods in evaluation of inflammatory bowel disease: where do we stand now? An update. Clinics (Sao Paulo). 2010;65(2):221-31. PMID: 20186307.

3. Koutroubakis IE, Petinaki E, Mouzas IA, Vlachonikolis IG, Anagnostopoulou E, Castanas E, Maniatis AN, Kouroumalis EA. Anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic autoantibodies in Greek patients with inflammatory bowel disease. Am J Gastroenterol. 2001;96(2):449-54. PMID: 11232689.

For educational use only, not a substitute for clinical judgement or medical advice. Consult qualified clinicians for diagnosis and treatment decisions. This tool may contain errors; use the flag button below to report inaccurate or harmful content.

Draft, generated by the IBDology RAG and not yet clinician-reviewed. Answers are grounded in the retrieved literature listed above; a high faithfulness score means the answer matches its sources, not that the sources are correct.